NewAmsterdam Pharma Company
NAMS
#4117
Rank
S$2.95 B
Marketcap
$31.99
Share price
6.54%
Change (1 day)
135.32%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2024 (TTM): -S$0.25 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are S$14.02 Million. In 2023 the company made an earning of -S$0.24 Billion a decrease over its 2022 earnings that were of -S$32.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2020 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$0.25 Billion5.5%
2023 -S$0.24 Billion628.66%
2022-S$32.21 Million-48.69%
2021-S$62.77 Million444.1%
2020-S$11.54 Million